New professor Lukas Dekker: improved identification and treatment of arrhythmias
Cardiologist-electrophysiologist Lukas Dekker of the Catharina Hospital was appointed part-time professor this month. His chair is called 'Technology for outcome-driven cardiac care'.
Dekker treats patients with cardiac arrhythmias at the Catharina Hospital, the largest cardiac center in the Netherlands. The new chair provides a further boost to the development of technological solutions to improve the quality of care for heart patients. "And by developing new applications, we also want to reduce the ever-increasing healthcare costs," says Dekker.
Dekker will be working at the Department of Electrical Engineering within the Signal Processing Systems group, and at the Biomedical Engineering department, in the Cardiovascular Biomechanics group. His inauguration is scheduled for 11 October.
In addition to research in an international network, he will contribute to the development of new techniques in Brainport Eindhoven to diagnose atrial fibrillation at the earliest possible stage. "By detecting the disease earlier, we can start treatment more quickly, thus preventing heart failure and strokes," says Dekker. In one of these studies he is working closely with the Kempenhaeghe sleep center to investigate the relationship between sleep disorders and cardiac arrhythmia.
New technology is also being developed to improve the invasive catheter treatment of atrial fibrillation. "And another ambition lies in the field of ventricular dysrhythmia, which can sometimes also have a fatal outcome. Using advanced imaging technologies and artificial intelligence, we want to better identify people at risk of ventricular arrhythmias.”
Dekker is one of the initiators of Eindhoven Medtech Innovation Center, in short e/MTIC. Within this collaborative partnership between the Eindhoven University, Philips, Kempenhaeghe Expertise Center,Máxima Medical Centre and the Catharina Hospital high-tech research is dedicated to developing and implementing medical innovations. The partners expect that the intensive cooperation between clinic, science and industry will significantly shorten the development time from research to relevant outcomes for the patient.